Release Date: 09/12/10 11:09 Summary: Change of Company Name to AdEffective Limited Price Sensitive: No Download Document 44.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%